Yet another Botox competitor coming: Xeomin

An article this week on Modern Medicine's website had a rundown of Botox's upcoming competitors.  It had two that have been mentioned repeatedly over the last few months: Dysport and PurTox not far behind, but it also threw in Xeomin, which is made by a company called Merz. 

Merz is a well-respected German company.  They sell other dermatology products in the US and will be well-received when they come to the Botox market in this country... Xeomin is already available in Europe.

Here's what ConsultingRoom.com had to say about it: 

"It is widely accepted that the bacterial protein present in other products play a role as promoters of an immune reaction, resulting in a loss of effect and reduction in duration of activity. Studies show that Xeomin(r), without the complexing proteins, has the lowest content of protein of all of the available botulinum toxins and furthermore show that repeated application of Xeomin(r), even in high doses, does not induce the formation of neutralising anti-bodies.

This means that Xeomin(r) is able to provide similar results to those achievable with the other products without the risk of antibody formation, providing continual long lasting effects. This could be relevant when large doses are being used for medical indications, but many industry experts questions the relevance when this product is used for cosmetic purposes."

Thanks for reading,

Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center, Boca Raton
Skin Laser Surgery Specialists of NY/NJ

Dr. Jason Pozner
Sanctuary Medical Aesthetic Center, Boca Raton
Sanctuary Plastic Surgery, Boca Raton